PhenomeX Inc. Common Stock
CELL
CELL was delisted on the 29th of September, 2023.
155 hedge funds and large institutions have $1.89B invested in PhenomeX Inc. Common Stock in 2021 Q1 according to their latest regulatory filings, with 64 funds opening new positions, 66 increasing their positions, 18 reducing their positions, and 22 closing their positions.
267% more repeat investments, than reductions
Existing positions increased: 66 | Existing positions reduced: 18
191% more first-time investments, than exits
New positions opened: 64 | Existing positions closed: 22
133% more funds holding in top 10
Funds holding in top 10: 3 → 7 (+4)
37% more funds holding
Funds holding: 113 → 155 (+42)
1% less call options, than puts
Call options by funds: $8.25M | Put options by funds: $8.33M
6% less capital invested
Capital invested by funds: $2.02B → $1.89B (-$129M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AIM
ARK Investment Management
St. Petersburg,
Florida
|
+$249M |
| 2 |
FAM
Fred Alger Management
New York
|
+$142M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$127M |
| 4 |
AllianceBernstein
Nashville,
Tennessee
|
+$52.6M |
| 5 |
JP Morgan Chase
New York
|
+$46.2M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SUT
SC US (TTGP)
Menlo Park,
California
|
-$219M |
| 2 |
N
Nuveen
Charlotte,
North Carolina
|
-$20.4M |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
-$19.3M |
| 4 |
HA
HHLR Advisors
Grand Cayman,
Cayman Islands
|
-$17.9M |
| 5 |
Victory Capital Management
San Antonio,
Texas
|
-$15.7M |
CELL Hedge Fund Activity: Q1 2021 in Review
155 of the 5,695 institutional investors tracked by Wall St. Rank reported a position in PhenomeX Inc. Common Stock (CELL) for Q1 2021, worth a combined $1.89B — down 6.4% from $2.02B a quarter earlier.
Buyers outnumbered sellers: 64 funds opened new CELL positions and 22 closed out — a net gain of 42 holders — while 66 added to existing stakes and 18 trimmed.
The largest buyer was ARK Investment Management, adding an estimated $249M. The largest seller was SC US (TTGP), cutting an estimated $219M.
- 155 institutional investors held PhenomeX Inc. Common Stock (CELL) as of Q1 2021, up from 113 in Q4 2020.
- Funds reported $1.89B of PhenomeX Inc. Common Stock stock for Q1 2021, down 6.4% quarter-over-quarter.
- 64 funds opened new PhenomeX Inc. Common Stock positions in Q1 2021 and 22 closed out, a net change of +42 holders.
- The largest PhenomeX Inc. Common Stock buyer in Q1 2021 was ARK Investment Management, an estimated $249M added.
- The largest PhenomeX Inc. Common Stock seller in Q1 2021 was SC US (TTGP), an estimated $219M sold.
Based on aggregated 13F filings for Q1 2021.